Each mL contains: Active Ingredient: Sodium hyaluronate 10 mg.
Excipients/Inactive Ingredients: Sodium Chloride 8.5 mg, monobasic sodium phosphate dihydrate 0.05 mg, Dibasic sodium Phosphate dodecahydrate 0.6 mg, water for injections q.s To add 1 mL.
Pharmacology: Mode of Action: Hyaluronic acid is the prototype of a wide range of saccharide biopolymers (glycosaminoglycans of mucopolysaccharides) which are important components of all extracellular matrices, including cartilage and synovial fluid.
The active ingredient in the speciality UMARONE is specific Hyaluronic acid fraction with a high degree of molecular definition and purity, isolated from cock's combs.
The introduction of this biological substance into joints with degenerating cartilage surface and pathologically altered synovial fluid results in improved joint function, thanks to the normalization of synovial fluid quality and the activation of tissue repair processes in articular cartilage.
Degenerative joint disease. Adjuvant in orthopaedic surgery.
Degenerative joint disease and adjuvant in orthopaedic surgery; According to joint size 2 mL or less are administered intra-articularly once a week. Treatment schedules tried so far have included up to 6 weekly injections.
More than one joint may be treated at the same time.
There are not known contra-indications to the intra-articular supply of exogenous hyaluronic acid.
It is necessary to follow a correct technique of intra-articular injection in accurately aseptic conditions, taking care not to cause tissue damage in the injection path.
Should be used with care in the presence of infection. Because of the danger of spreading the infections, it should not be injected in or around an infected area.
Malignancy may similarly be a contra-indication. Should not be given intravenously.
Joint swelling and/or local pain may occur after intra-articular injection into a minority of patients. Such symptoms are transient and will disappear in a few hours.
Hypersensitivity may occur occasionally.
Administration of salicylates antagonizes the action of hyaluronidase.
Do not use Umarone if package is opened or damaged. Store in original packaging in temperature (protected from light) not exceeding 25°C.
The expiry date reported on the package refers to the product stored correctly in its original package.
Warnings: Do not use the product after the expiry date reported on the package.
Keep out of reach of children.
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
Umarone inj 10 mg/mL
2 mL x 1's
Sign Out
Lanjutkan dengan Google
Daftar dengan Email
Sudah menjadi anggota?
Masuk
